Epidemiology and cardiovascular risk factors of aortic stenosis

被引：77

作者：

Faggiano P. ^{[1
]}

Antonini-Canterin F. ^{[2
]}

Baldessin F. ^{[2
]}

Lorusso R. ^{[3
]}

D'Aloia A. ^{[1
]}

Dei Cas L. ^{[1
]}

机构：

[1] Cattedra di Cardiologia, Università di Brescia, Ospedali Civili di Brescia

[2] Divisione di Cardiologia, Azienda Ospedaliera Santa Maria degli Angeli di Pordenone

[3] Divisione di Cardiochirurgia, Ospedali Civili di Brescia

来源：

Cardiovascular Ultrasound | / 4卷 / 1期

关键词：

Aortic Valve; Aortic Stenosis; Aortic Valve Stenosis; Aortic Valve Disease; Ischemic Mitral Regurgitation;

D O I：

10.1186/1476-7120-4-27

中图分类号：

学科分类号：

摘要：

The abnormalities of aortic valve morphology and function represent the most common cardiac-valve lesion particularly in elderly. The etiology of aortic stenosis is degenerative-calcific in the majority of patients. Many risk factors seems to be linked to the calcification and the stenosis of the aortic valve but they must be confirmed. In this review the etiology and the possible physiopathology of the aortic valve stenosis is discussed. © 2006 Faggiano et al; licensee BioMed Central Ltd.

引用

共 17 条

[1]

Passik C.S., Ackermann D.M., Pluth J.R., Edwards W.D., Temporal changes in the causes of aortic stenosis: A surgical pathologic study of 646 cases, Mayo Clin Proc, 62, (1987)

[2]

Cleland J.G., Swedberg K., Follath F., Komajda M., Cohen-Solal A., Aguilar J.C., Dietz R., Gavazzi A., Hobbs R., Korewicki J., Madeira H.C., Moiseyev V.S., Preda I., Van Gilst W.H., Widimsky J., Freemantle N., Eastaugh J., Mason J., Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. the EuroHeart Failure survey programme- A survey on the quality of care among patients with heart failure in Europe, Eur Heart J, 24, (2003)

[3]

Hasdai D., Lev E.I., Behar S., Boyko V., Danchin N., Vahanian A., Battler A., Acute coronary syndromes in patients with pre-existing moderate to severe valvular disease of the heart: Lessons from the Euro-Heart Survey of acute coronary syndromes, Eur Heart J, 24, (2003)

[4]

Iung B., Baron G., Butchart E.G., Delahaye F., Gohlke-Barwolf C., Levang O.W., Tornos P., Vanoverschelde J.L., Vermeer F., Boersma E., Ravaud P., Vahanian A., A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease, Eur Heart J, 24, (2003)

[5]

Lindroos M., Kupari M., Heikkila J., Tilvis R., Prevalence of aortic valve abnormalities in the elderly: An echocardiographic study of a random population sample, J Am Coll Cardiol, 21, (1993)

[6]

Stewart B.F., Siscovick D., Lind B.K., Gardin J.M., Gottdiener J.S., Smith V.E., Kitzman D.W., Otto C.M., Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study, J Am Coll Cardiol, 29, (1997)

[7]

Brown M., Palmer C., Castaigne A., De Leeuw P., Mancia G., Rosenthal T., Ruilope L., Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT), The Lancet, 356, (2000)

[8]

Olsen M.H., Wachtell K., Bella J.N., Liu J.E., Boman K., Gerdts E., Papademetriou V., Nieminen M.S., Rokkedal J., Dahlof B., Devereux R.B., Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy), The Am J Cardiol, 94, (2004)

[9]

Branch K.R., O'Brien K.D., Otto C.M., Aortic valve sclerosis as a marker of active atherosclerosis, Curr Cardiol Rep, 4, (2002)

[10]

Otto C.M., Lind B.K., Kitzman D.W., Gersh B.J., Siscovick D.S., The Cardiovascular Health Study. Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly, N Engl J Med, 341, (1999)

← 1 2 →